Skip to main content

ESTUDIO DE LOS DETERMINANTES VIRALES Y CELULARES RESPONSABLES DE LA INTEGRACION DEL DNA DEL VIRUS DE LA HEPATITIS B

PID2020-118970RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture.

  • Álvarez, Eva G
  • Demeulemeester, Jonas
  • Otero, Paula
  • Jolly, Clemency
  • García-Souto, Daniel
  • Pequeño-Valtierra, Ana
  • Zamora, Jorge
  • Tojo, Marta
  • Temes, Javier
  • Baez-Ortega, Adrian
  • Rodriguez-Martin, Bernardo
  • Oitaben, Ana
  • Bruzos, Alicia L
  • Martínez-Fernández, Mónica
  • Haase, Kerstin
  • Zumalave, Sonia
  • Abal, Rosanna
  • Rodríguez-Castro, Jorge
  • Rodriguez-Casanova, Aitor
  • Diaz-Lagares, Angel
  • Li, Yilong
  • Raine, Keiran M
  • Butler, Adam P
  • Otero, Iago
  • Ono, Atsushi
  • Aikata, Hiroshi
  • Chayama, Kazuaki
  • Ueno, Masaki
  • Hayami, Shinya
  • Yamaue, Hiroki
  • Maejima, Kazuhiro
  • Blanco, Miguel G
  • Forns, Xavier
  • Rivas, Carmen
  • Ruiz-Bañobre, Juan
  • Pérez-Del-Pulgar, Sofía
  • Torres-Ruiz, Raul
  • Rodriguez Perales, Sandra
  • Garaigorta, Urtzi
  • Tubio, Jose M C
  • Campbell, Peter J
  • Nakagawa, Hidewaki
  • Van Loo, Peter
Most cancers are characterized by the somatic acquisition of genomic rearrangements during tumour evolution that eventually drive the oncogenesis. Here, using multiplatform sequencing technologies, we identify and characterize a remarkable mutational mechanism in human hepatocellular carcinoma caused by Hepatitis B virus, by which DNA molecules from the virus are inserted into the tumour genome causing dramatic changes in its configuration, including non-homologous chromosomal fusions, dicentric chromosomes and megabase-size telomeric deletions. This aberrant mutational mechanism, present in at least 8% of all HCC tumours, can provide the driver rearrangements that a cancer clone requires to survive and grow, including loss of relevant tumour suppressor genes. Most of these events are clonal and occur early during liver cancer evolution. Real-time timing estimation reveals some HBV-mediated rearrangements occur as early as two decades before cancer diagnosis. Overall, these data underscore the importance of characterising liver cancer genomes for patterns of HBV integration.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells

  • Gómez-Moreno, Andoni
  • San Sebastian, Enara
  • Moya, Jennifer
  • Gomollón-Zueco, Pilar
  • Isola, Sergio
  • Vales, África
  • González-Aseguinolaza, Gloria
  • Unzu, Carmen
  • Garaigorta, Urtzi
Gene therapy is a promising strategy to treat and cure most inherited metabolic liver disorders. Viral vectors such as those based on adeno-associated viruses (AAVs) and lentiviruses (LVs) are used as vehicles to deliver functional genes to affected hepatocytes. Adverse events associated with the use of high vector doses have motivated the use of small molecules as adjuvants to reduce the dose. In this study, we showed that a one-hour treatment with topoisomerase inhibitors (camptothecin and etoposide) prior to viral transduction is enough to increase AAV and LV reporter expression in non-dividing hepatic cells in culture. Topoisomerase inhibitors increased both integration-competent (ICLV) and integration-deficient (IDLV) LV-derived expression, with a much stronger increase in the IDLV transduction system. In agreement with that, topoisomerase inhibitors increased viral genome integration in both strains, with a greater impact on the IDLV strain, supporting the idea that topoisomerase inhibitors increased episomal DNA integration, especially when viral integrase activity is abolished. These effects correlated with an increase in the DNA damage response produced by the treatments. Our study highlights the need to monitor DNA damage and undesired integration of viral episomal DNAs into the host genome when studying chemical compounds that increase viral transduction., This study has been financially supported by grants awarded to U.G.: grant PID2020- 118970RB-100 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”, and grant CNS2022_135593 funded by MCIN/AEI/10.13039/501100011033 and by “Euro- pean Union NextGenerationEU/PRTR”. A.G.-M. was supported by an FPU fellowship (FPU17/03424) from Ministerio de Educación, Cultura y Deporte., Peer reviewed